New patent for Stemline Therap drug ORSERDU

Annual Drug Patent Expirations for ORSERDU Orserdu is a drug marketed by Stemline Therap and is included in one NDA. It is available from one supplier. There are seven patents…

The post New patent for Stemline Therap drug ORSERDU appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog